Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/JNJ-42847922> ?p ?o }
Showing triples 1 to 47 of
47
with 100 triples per page.
- JNJ-42847922 abstract "JNJ-42847922 is a selective antagonist of the orexin OX2 receptor which is under investigation by Janssen Research & Development for the treatment of major depressive disorder and insomnia. As of December 2014, it has completed phase I clinical trials.".
- JNJ-42847922 wikiPageExternalLink 800040115.
- JNJ-42847922 wikiPageExternalLink sleep-2015-abstract-supplement.pdf?sfvrsn=4.
- JNJ-42847922 wikiPageExternalLink mediabstracts2015.pdf.
- JNJ-42847922 wikiPageID "46752815".
- JNJ-42847922 wikiPageLength "2914".
- JNJ-42847922 wikiPageOutDegree "15".
- JNJ-42847922 wikiPageRevisionID "663737610".
- JNJ-42847922 wikiPageWikiLink Almorexant.
- JNJ-42847922 wikiPageWikiLink Category:Antidepressants.
- JNJ-42847922 wikiPageWikiLink Category:Hypnotics.
- JNJ-42847922 wikiPageWikiLink Category:Orexin_antagonists.
- JNJ-42847922 wikiPageWikiLink Clinical_trial.
- JNJ-42847922 wikiPageWikiLink Filorexant.
- JNJ-42847922 wikiPageWikiLink Hypocretin_(orexin)_receptor_2.
- JNJ-42847922 wikiPageWikiLink Insomnia.
- JNJ-42847922 wikiPageWikiLink Janssen_Pharmaceutica.
- JNJ-42847922 wikiPageWikiLink Janssen_Research_&_Development.
- JNJ-42847922 wikiPageWikiLink Lemborexant.
- JNJ-42847922 wikiPageWikiLink MIN-202.
- JNJ-42847922 wikiPageWikiLink Major_depressive_disorder.
- JNJ-42847922 wikiPageWikiLink Phases_of_clinical_research.
- JNJ-42847922 wikiPageWikiLink Receptor_antagonist.
- JNJ-42847922 wikiPageWikiLink Suvorexant.
- JNJ-42847922 wikiPageWikiLinkText "JNJ-42847922".
- JNJ-42847922 hasPhotoCollection JNJ-42847922.
- JNJ-42847922 wikiPageUsesTemplate Template:Drugbox.
- JNJ-42847922 wikiPageUsesTemplate Template:Nervous-system-drug-stub.
- JNJ-42847922 wikiPageUsesTemplate Template:Neuropeptidergics.
- JNJ-42847922 wikiPageUsesTemplate Template:Notability.
- JNJ-42847922 wikiPageUsesTemplate Template:Reflist.
- JNJ-42847922 subject Category:Antidepressants.
- JNJ-42847922 subject Category:Hypnotics.
- JNJ-42847922 subject Category:Orexin_antagonists.
- JNJ-42847922 hypernym Antagonist.
- JNJ-42847922 type ChemicalSubstance.
- JNJ-42847922 type Drug.
- JNJ-42847922 type ChemicalObject.
- JNJ-42847922 type Thing.
- JNJ-42847922 type Q8386.
- JNJ-42847922 comment "JNJ-42847922 is a selective antagonist of the orexin OX2 receptor which is under investigation by Janssen Research & Development for the treatment of major depressive disorder and insomnia. As of December 2014, it has completed phase I clinical trials.".
- JNJ-42847922 label "JNJ-42847922".
- JNJ-42847922 sameAs m.0138s04n.
- JNJ-42847922 sameAs Q20708040.
- JNJ-42847922 sameAs Q20708040.
- JNJ-42847922 wasDerivedFrom JNJ-42847922?oldid=663737610.
- JNJ-42847922 isPrimaryTopicOf JNJ-42847922.